Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-2181PMID 15753388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.

  2004cited by this paper
• Role of KIT and platelet-derived growth factor receptors as oncoproteins.

  2004influential reference
• Discontinuation of imatinib therapy after achieving a molecular response.

  2004cited by this paper
• Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.

  2004cited by this paper
• Leydig Cell Tumors of the Testis

  2004cited by this paper
• Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells*

  2004cited by this paper
• Expression of Platelet-Derived Growth Factor (PDGF) in the Epididymis and Analysis of the Epididymal Development in PDGF-A, PDGF-B, and PDGF Receptor β Deficient Mice

  2004cited by this paper
• Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.

  2003cited by this paper
• Gynaecomastia in men with chronic myeloid leukaemia after imatinib.

  2003cited by this paper
• Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.

  2003cited by this paper
• Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

  2003cited by this paper
• Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.

  2003cited by this paper
• Pdgfr-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad.

  2003cited by this paper
• Hypoxia induces an autocrine‐paracrine survival pathway via platelet‐derived growth factor (PDGF)‐B/PDGF‐β receptor/phosphatidylinositol 3‐kinase/Akt signaling in RN46A neuronal cells

  2003cited by this paper
• Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro.

  2003cited by this paper
• Biology of platelet-derived growth factors in development.

  2003cited by this paper
• Regulation of Postnatal Lung Development and Homeostasis by Estrogen Receptor β

  2003cited by this paper
• Expression of Platelet-Derived Growth Factor-A (PDGF-A), PDGF-B, and PDGF Receptor-α and -β during Human Testicular Development and Disease

  2002cited by this paper
• Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies.

  2002influential reference
• Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype

  2002cited by this paper
• Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway.

  2002cited by this paper
• Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease.

  2002cited by this paper
• Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

  2002influential reference
• Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents.

  2001cited by this paper
• Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

  2001cited by this paper
• Stem cell factor functions as a survival factor for mature Leydig cells and a growth factor for precursor Leydig cells after ethylene dimethane sulfonate treatment: implication of a role of the stem cell factor/c-Kit system in Leydig cell development.

  2000cited by this paper
• Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.

  2000cited by this paper
• Leydig Cell Loss and Spermatogenic Arrest in Platelet-Derived Growth Factor (Pdgf)-a–Deficient Mice

  2000cited by this paper
• The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

  2000cited by this paper
• Role of 1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL + Leukemic Cells to the Abl Inhibitor STI 571

  2000cited by this paper
• Overexpression of aromatase leads to development of testicular leydig cell tumors : an in vivo model for hormone-mediated TesticularCancer.

  2000cited by this paper
• Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.

  1999cited by this paper
• Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor.

  1999cited by this paper
• Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.

  1998cited by this paper
• Coexpression of Multiple Sertoli Cell and Leydig Cell Marker Genes in the Spontaneous Testicular Tumor of F344 Rat: Evidence for Phenotypical Bifurcation of the Interstitial Cell Tumor

  1997cited by this paper
• The leydig cell

  1996cited by this paper
• An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis.

  1995cited by this paper
• A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

  1993cited by this paper
• Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules.

  1992cited by this paper
• Leydig cell tumors of the testis: A clinicopathological analysis of 40 cases and review of the literature

  1985cited by this paper
• Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.

  1976cited by this paper
• Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.

  1976cited by this paper

• Imatinib‑induced gynecomastia: A case report

  2024cites this paper
• A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database

  2020cites this paper
• Tumors of the Male Reproductive System

  2019cites this paper
• Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction

  2019cites this paper
• Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.

  2018cites this paper
• The Human Leydig Cell

  2018cites this paper
• The Human Leydig Cell

  2017cites this paper
• Imatinib alters cell viability but not growth factors levels in TM4 Sertoli cells

  2016cites this paper
• The Effects of Imatinib Mesylate on Cellular Viability, Platelet Derived Growth Factor and Stem Cell Factor in Mouse Testicular Normal Leydig Cells

  2016cites this paper
• CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment.

  2016cites this paper
• Sex Cord-Stromal Tumors of the Testis

  2016cites this paper
• The mechanisms of toxicity of Dibutyl Phthalate (DBP) in cultured cells.

  2016cites this paper
• Leydig cell tumor with lung metastasis diagnosed by lung biopsy.

  2015cites this paper
• Genome-wide association study using deregressed breeding values for cryptorchidism and scrotal/inguinal hernia in two pig lines

  2015cites this paper
• Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit)

  2015influential citation
• Imatinib binding to human serum albumin modulates heme association and reactivity.

  2014cites this paper
• Obesity and Metabolic Comorbidities: Environmental Diseases?

  2013cites this paper
• Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4.

  2011cites this paper
• Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer.

  2011cites this paper
• Fertilité, grossesse, allaitement et état de santé des nouveau-nés chez les patient(e)s souffrant de LMC-PC et raité(e)s par inhibiteurs de la tyrosine kinase: Recommandations de groupe Fi-LMC

  2011cites this paper
• The role of platelet-derived growth factor in radiation injury to the lower urinary tract

  2011cites this paper
• Expression of KIT in the ovary, and the role of somatic precursor cells.

  2011cites this paper
• Immunohistochemical expression of the KIT protein (CD117) in normal and neoplastic canine testes.

  2010cites this paper
• Controlling the Mdm2-Mdmx-p53 Circuit

  2010cites this paper
• Role of platelet-derived growth factors in the testis.

  2010cites this paper
• Endocrine side effects of broad-acting kinase inhibitors.

  2010cites this paper
• On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: an in vitro study.

  2009cites this paper
• Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.

  2008cites this paper
• [Imatinib and solid tumours].

  2008cites this paper
• Expression of C-kit and Platelet-Derived Growth Factor Receptors in Ovarian Granulosa Cell Tumors

  2008cites this paper
• Der Stellenwert der Targeted-Therapie beim Hodentumor

  2008cites this paper
• Platelet-derived growth factor receptor beta-subtype regulates proliferation and migration of gonocytes.

  2008cites this paper
• [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

  2008cites this paper
• Molecular Therapy in Urologic Oncology

  2007cites this paper
• Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.

  2007cites this paper
• Leydig cell tumor and hyperplasia: a review.

  2007cites this paper
• Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.

  2007cites this paper
• Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells

  2007cites this paper
• The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2

  2007cites this paper
• PDGF receptors as targets in tumor treatment.

  2007cites this paper
• Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

  2007cites this paper
• The role of PDGF in radiation oncology

  2007cites this paper
• Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.

  2007cites this paper
• Tumor das células de Leydig: relato de caso

  2007cites this paper
• Kit and PDGFR-α activities are necessary for Notch4/Int3-induced tumorigenesis

  2007cites this paper
• Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor

  2006cites this paper
• Imatinib mesilate: new perspectives in the treatment of solid tumours

  2006cites this paper
• Rare Tumors of the Testis and Paratesticular Tissues

  2006cites this paper
• Mechanisms of sarcoma development

  2003cites this paper